tiprankstipranks
Advertisement
Advertisement

Greenland Mines Rebrands and Launches Dual-Focus Strategy

Story Highlights
  • Klotho Neurosciences rebranded as Greenland Mines Ltd on March 12, 2026, adopting the Nasdaq ticker GRML and updating shareholders’ holdings automatically.
  • The company highlighted its dual focus on the Skaergaard mining project and ALS cell and gene therapy, signaling a strategic shift to blend resource development with biotech growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Greenland Mines Rebrands and Launches Dual-Focus Strategy

Claim 55% Off TipRanks

Greenland Mines ( (GRML) ) has provided an announcement.

On March 12, 2026, Klotho Neurosciences, Inc. completed a rebranding to Greenland Mines Ltd and began trading on the Nasdaq Capital Market under the new ticker symbol GRML, with existing shareholders’ positions automatically updated and the CUSIP number unchanged. The company also scheduled an investor webcast that day to explain the strategic rationale for its recent acquisition and its expected benefits for shareholders, underscoring a shift in identity that integrates a major Greenland mining asset with its ongoing cell and gene therapy programs.

The move formalizes Greenland Mines’ dual focus on developing the Skaergaard Project, a large palladium, gold, and platinum resource in southeast Greenland, and advancing its KLTO-202 ALS therapy in the biotech sphere. By highlighting its 80% stake and option on the remaining interest in Skaergaard and drawing attention to extensive mineral resource estimates, the company signaled an ambition to leverage both mining and biotech capabilities, a strategy that could reshape its risk profile and appeal to a broader investor base despite the early-stage nature of the mining project.

More about Greenland Mines

Greenland Mines Ltd, formerly Klotho Neurosciences, Inc., is a Nasdaq-listed company operating in two divisions: Natural Resources and Cell and Gene Therapy. The natural resources arm focuses on exploring and developing the Skaergaard Project in southeast Greenland, one of the largest undeveloped palladium, gold, and platinum deposits, while the biotech division advances KLTO-202 for ALS.

Through the recent acquisition of Greenland Mines Corp., the company holds an 80% interest and an option on the remaining 20% of Skaergaard, which has a 2022 NI 43-101 Indicated and Inferred Mineral Resource of 25.4 Moz PdEq and 23.5 Moz AuEq. Led by a team with mining, geological, biotech, and capital markets expertise, Greenland Mines is positioning itself at the intersection of resource development and advanced therapeutics.

Average Trading Volume: 3,264,989

Technical Sentiment Signal: Sell

Current Market Cap: $30.16M

For an in-depth examination of GRML stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1